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Summary: 13C-NMR spectroscopy was used as
a noninvasive approach to study the metabolism
of [ 1,3-13C]octanoate in rat liver. Using a proper-
ly adjusted surface coil a liver selection of better
than 90% was achieved in the intact animal
without abdominal surgery. After infusion of
[ l,3-13C]octanoate via the jugular vein different
patterns of metabolites were observed depending
on the physiological state of the rat. In the
fasted animal, the major metabolites were those
of the Krebs cycle while in the diabetic animal
ketogenic end products were predominant. As a
fatty acid of medium chain length octanoate is
imported into the inner mitochondrial space
without control by the carnitine acyl transferase
system. Hence, the metabolic differences ob-
served between diabetic and fasted rats result
from an intramitochondrial control mechanism.
The in vivo 13C-NMR results therefore support
previous biochemical in vitro studies which con-
cluded that a major control of ketone body
production occurs in the inner mitochondrial
space, presumably via the redox potential of the
liver. As an unexpected result, 13C-NMR provi-
des evidence for the transitory esterification of
the infused 13C-labeled octanoic acid. The cor-
responding 13C-NMR chemical shifts are typical
for glycerides.
13C-NMR-Spektroskopische Untersuchungen der Ketogenese beider Ratte in vivo.
Infusion von [l,3-13C]Octanoat
Zusammenfassung: Mittels der 13C-NMR Spek-
troskopie wurde der Metabolismus von [1,3-13C]-
Octanoat in der Leber von fastenden und diabe-
tischen Ratten auf nicht-invasive Weise unter-
sucht. Durch geeignete Wahl des Spulendurch-
messers und der Meßbedingungen und durch
sorgfältige Positionierung der Oberflächenspule
konnte ohne chirurgischen Eingriff eine Leber-
selektion von besser als 90% erreicht werden.
Nach Infusion von [l,3-13C]Octanoat durch die
Halsvene der Ratte wurden abhängig vom Zu-
stand des Tieres unterschiedliche Metabolite
beobachtet. Im fastenden Tier dominierten
Metabolite des Krebszyklus, während im diabe-
tischen Tier die Ketonkörper die wichtigste
Rolle spielten. Octansäure wird unter Umge-
hung des Carnitin-Acyl-Transferase-Systems in
die Lebermitochondrien transportiert. Die Pro-
duktion unterschiedlicher Metabolite im
fastenden und diabetischen Tier kann daher
nur durch einen intramitochondrialen Kontroll-
mechanismus erklärt werden. Die In-vivo-13C-
NMR-Messungen sind daher im Einklang mit
biochemischen in-vitro-Unterschungen, aus de-
nen eine Kontrolle der Ketonkörperproduktion
durch das Redoxpotential der Leber abgeleitet
wurde. Die 13C-NMR-Experimente zeigen zu-
sätzlich eine transitorische In-vivo-Veresterung
der markierten Octansäure der Leber. In der
biochemischen Literatur wurde eine direkte Ver-
esterung von Octansäure bisher ausgeschlossen.
Die beobachteten chemischen Verschiebungen
stimmen mit Literaturdaten für Glycerol-ester
überein.
Key words: Ketogenesis in vivo, 13C-NMR spectroscopy, octanoate metabolism, triacylglycerol esters, diabetic rat
liver.
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The production of ketone bodies in the mam-
malian liver is closely related to the availability
of fatty acids as substrates for jS-oxidation. Free
fatty acids are released from the adipose tissue
and transported to the liver. Two major regula-
tory steps can be recognized in the liver for the
control of ketogenesis:
1) the regulation of the entry of free fatty acids
into the mitochondria via the acyl carnitine
transferase system,
2) the regulation of the relative fluxes of acetyl-
CoA through the pathways of oxidation to
CO2 (via the citric acid cycle) and of keto-
genesis.
In order to investigate the intrahepatic regula-
tory mechanisms for ketogenesis we have
studied the metabolism of 13C-labeled fatty acids
in the liver of diabetic and fasted rats in vivo. As
a non-invasive approach we have used the re-
cently developed technique of in vivo 13C-NMR
spectroscopy which allows the study of 13C-
labeled metabolites in rat liver without the need
for abdominal surgery. A variety of metabolites
can be identified and quantitated with 13C-NMR
and the time-course of their synthesis and de-
gradation can be followed in a single experi-
ment.
We have reported earlier on experiments with
fasted and diabetic rats using l3C-labeled buty-
rate as a substrate and have also described in
detail the 13C-NMR technique11·21. Here we
present experiments obtained with a fatty acid
of medium chain length, i.e. l,3-13C-labeled
octanoate. Common to medium and short chain
fatty acids is their property to bypass the acyl
carnitine transferase system. Both enter freely
into the mitochondrial inner space and the re-
gulatory mechanism governing their metabolism
is determined exclusively by the pathways of
j3-oxidation.
The present octanoate studies revealed clear dif-
ferences in the fate of the substrate depending
on the physiological state of the animal. Whereas
in the diabetic rat liver the major part of the
13C-labeled acetyl-CoA was converted into
ketone-bodies, [l-13C]acetyl-CoA produced in
the fasted rat liver was directed preferentially
towards oxidation to CO2 via the citric acid
cycle.
13C-labeled glucose was observed under in vivo
conditions only in the diabetic rat but not in
fasted animals indicating a high activity of the
malate shuttle in the former. NADH which is
produced in excess by the oxidation of fatty
acids is exported via the malate shuttle from the
mitochondria into the cytosol where it is con-
sumed in gluconeogenesis. The enhanced glu-
coneogenesis encountered in the diabetic state
allows an increased 0-oxidation of fatty acids
which may be otherwise soon limited by respi-
ratory control.
In earlier studies performed with 14C-labeled
octanoate on the perfused livers of diabetic and
fasted rats, essentially the same amount of
labeled ketone-bodies was observed for both
conditions. The authors therefore concluded
that the major control of ketogenesis was ex-
erted by the regulation of the entry of free
fatty acid into the mitochondriai3>41. In contrast,
the present results support the concept of
Lehningerls] and Wieland16'71 that the availabil-
ity of free oxaloacetate and hence the redox-




Fourier transform NMR spectra were obtained in vivo
with a Bruker BNT-80 spectrometer with a 1 .9 T hori-
zontal magnet having a clear bore of 24 cm. A Waltz-8
pulse sequence was used to obtain complete 1 H-de-
coupling with minimal radio frequency power. The liver
selection was achieved with a surface coil of 1 .8 cm dia-
meter and a special rat support. The experimental condi-
tions where identical to those detailed previously f 1 » 2 ^ .
The methyl groups of phosphatidylcholine were used as
an internal standard for the quantitative comparison of
the 13C-NMR spectra. Partial saturation of the non-
protonated carbonyl resonances compared to the faster
relaxing protonated carbon atoms was taken into ac-
count by an experimentally determined correction factor
Chemicals
[ l,3-13C]octanoate (90% enrichment) was prepared
from pentyliodide by three chain elongations with
CO2i81. In the first and third elongation step 13CO2
(90%) was employed. The overall yield in the 8-step
synthesis was 5-10% based on the amount of Ba13CO3
employed in the first Grignard reaction.
Animals
Male rats (Sprague-Dawley-strain, 250-300 g) were
used for all experiments. They were fed ad libitum with
standard rat chow. Fasted rats were deprived of food
for 24 h prior to use. Experimental diabetes was in-
duced by the intraveneous injection of streptozotocin
(90 mg/kg body weight). Animals were used 48 h later
if they proved to be acutely ketotic as determined by an
immediate strongly positive urine test for ketones
(ketomerckognost, Merck, Darmstadt). They were fed
ad libitum until they were used. No octanoate infusion
experiments were performed with well-nourished rats.
In previous experiments with labeled butyric acid we
noted only weak 13C metabolite signals with well-
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 11/14/17 12:11 PM
Vol. 368 (1987) Ketogenesis in vivo Followed by 13C-NMR 207
nourished rats presumably because of the overriding
abundance of non-labeled endogenous fatty acids^.
Infusion experiments
Rats were anesthetized with pentobarbital (50 mg/kg,
intraperitoneally). A catheter was placed in the right
jugular vein and maintained patent with isotonic saline
solution infused at 0.5 m//h. The labeled octanoate was
infused as a 0.2M solution (pH 7.3) with 3% albumin.
The infusion rate was adjusted to 6 m//h, the total
volume infused per experiment was 10 m/ corresponding
to 2 mmol of labeled octanoate. The in vivo liver spectra
were recorded with a surface coil. For the extracts and
for the in vitro spectra the liver was excised after termi-
nation of the infusion and immediately frozen in liquid
nitrogen. The lipids were extracted according to the
procedure of Folch'9!. For high resolution 13C-NMR
spectra at 75 MHz the liver was sliced and transferred
into a 10 mm sample tube. Saline in 2H2O was added
as lock signal. The temperature was kept at 37 °C. All
experiments were performed at least in duplicate and
the scatter between experiments of the same series was
surprisingly small as judged from the scatter in the
intensities of corresponding resonances.
Lipase treatment
Slices of excised livers from diabetic rats which had been
infused with [l,3-13C]octanoate were incubated in an
NMR tube with lipase (from Rhizopus delemar, 600 U/
mg, Fluka AG). This enzyme cleaves selectively the car-
bonyl ester bond of triacyl glycerols. The temperature
was maintained at 37 °C and the enzymatic degradation
of the glycerol esters was followed by NMR.
Results
Fig. 1 displays in vivo 13C-NMR spectra of the
liver of a fasted rat. The resonance of the phos-
phatidylcholine methyl groups at 55 ppm was
used as an internal standard to scale the differ-
ent spectra^21. Fig. 1A represents the natural
abundance 13C signals at the beginning of the in-
fusion period, while Fig. IB shows the same
liver after infusion of [l,3-13C]octanoate. Each
spectrum was acquired during a period of 40 min.
A 180° flip angle in the center of the coil was
applied to suppress signals from superficial tis-
sue. Fig. 1C shows the difference spectrum B-A
Fig. 1. 13C-NMR spectra of in vivo rat
liver observed in a fasted animal.
Spectra were obtained at 20.1 MHz with a
surface coil and a 13C 180° surface nulling
pulse. Proton decoupling was employed only
during the 100 ms aquisition time. [ 1,3-13C]-
octanoate was infused via the jugular vein
over a period of 110 min. (A) Spectral
acquisition from 20 min before to 20 min
after start of infusion; (B) spectral aquisi-
tion for the period 80-120 min after start
of infusion; (C) difference spectrum (B) —
(A) showing only resonances of metabolized
[ 1,3-13C]octanoate. Assignment of reso-
nances according to Table 1. Each spectrum
represents 2000 aquisitions. An artificial
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in which the natural abundance 13C background
is eliminated and where only those resonances
are retained which result from the metabolism
of [ 1,3-13C]octanoate. Most signals are clustered
in the region of the carbonyl groups around
170 ppm and the assignment of the resonances
is summarized in Table 1. The most intense
resonances in Fig. 1C arise from metabolites of
the citrate cycle, in particular glu tarn ate C(5)
(resonance 2 at 181.4 ppm), glutamine C(5)
(resonance 4 at 177.8 ppm), and hydrogen
carbonate (resonance 8 at 160 ppm). Reso-
nances of the free substrate were not observed;
however, resonances 14 at 172 ppm and 15 at
24.9 ppm must be assigned to C(l) and C(3)
of octanoate bound as glycerolester (cf. below).
Corresponding spectra were obtained for dia-
betic animals and are shown in Fig. 2. Fig. 2A






















































Fig. 2. 13C-NMR spectra of in vivo rat
liver observed in a diabetic animal.
Infusion of [l,3-13C]octanoate. Other
experimental conditions as in Fig. 1. (A)
Spectral aquisition from 20 min before
to 20 min after start of infusion; (B)
80-120 min after start of infusion; (C)
difference spectrum (B) — (A) showing
only intrahepatic metabolites derived
from [l,3-13C]octanoate (cf. Table 1
for assignment).
190
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shows the natural abundance 13C liver spectrum
of the diabetic rat, Fig. 2B represents the spec-
trum after infusion of [l,3-13C]octanoate, and
Fig. 2C gives the difference spectrum B-Α. Com-
pared to the fasted animal, resonances from
glutamine and carbonate are missing; instead
new resonances appear which can be assigned
to the ketone bodies β-hydroxybutyrate C(l):
resonance 3 at 180.5 ppm; C(3): resonance 12
at 65.7 ppm) and acetoacetate (C(l): resonance
5 at 175 ppm). Again a considerable fraction of
[l,3-13C]octanoate occurs in the form of its
glycerol ester (resonance 14 at 172 ppm and
resonance 15 at 24.5 ppm).
The 13C labeling pattern observed after infusion
of [1,3-13C]octanoate is in broad agreement
with previous results obtained with [1,3-13C]-
butyrate as a substrate121. In fasted rats, both
studies demonstrate that the 13C-labeled fatty
acids are converted essentially to products of
the citrate cycle, i.e. glutamate, glutamine, and
hydrogen carbonate. Likewise, the major meta-
bolite in the liver of the diabetic animal was
found to be 3-hydroxybutyrate in both cases.
However, an interesting difference should also
be noted. The formation of acetoacetate under
in vivo conditions could only be detected with
[l,3-13C]octanoate but not with [l,3-13C]buty-
rate. Even though acetoacetate was also produced
from butyrate, its concentration in the liver was
too low to be seen in the in vivo experiment.
Only when perchloric acid extracts of the liver
were prepared was it possible to demonstrate the
formation of this metabolite. In contrast, the
C(l) resonance of acetoacetate was readily ob-
servable both in diabetic and fasted rat liver in
vivo with [l,3-13C]octanoate as substrate. In
fact, with a long enough measuring time it was
also possible to detect the C(3) resonance of
acetoacetate at 210 ppm (cf. insert in Fig. 3)
which is characterized by an inherently low
sensitivity due to a long T t relaxation time.
A further similarity in the metabolism of infused
butyrate and octanoate was the formation of
13C labeled glucose in the diabetic rat. Fig. 3
shows the in vivo liver spectrum of a diabetic rat
acquired over a measuring period of l h with
simultaneous infusion of [l,3-13C]octanoate. In
addition to the resonances already discussed, a
new resonance appeared at 70.1 ppm (resonance
11) and was assigned to C(4) of a- and 0-glucose.
At a later stage of the same experiment a further
resonance appeared at 76.1 ppm and was as-
signed to the C(3) resonance of j3-glucose. Since
the glucose signals in the in vivo spectra are
rather weak further assignments were made with
perchloric acid extracts of liver slices. The spec-




Fig. 3. 13C-NMR spectrum of in vivo rat liver of a diabetic animal.
The spectrum was aquired over a period of l h during the infusion of [ 1,3-13C]octanoate. (B) Shows the expanded
region between 200 and 220 ppm. Assignment of resonances according to Table 1. 3000 aquisitions. An artificial line
broadening of 2 Hz was used.
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Fig. 4. 13C-NMR spectra (at 75.5 MHz) of the perchloric
acid extracts of rat liver.
(A) Obtained from a control animal, (B) from a diabetic
animal after infusion of [ 1,3-13C]octanoate; (C) differ-
ence spectrum (B) - (A) showing only those glucose
resonances which have been 13C-labeled during the in-
fusion of [ 1,3-13C]octanoate. In (B) and (C) the intense
signal of 3-hydroxybutyrate is truncated. Resonance
assignment of the glucose signals in (A):
a at 96.1 ppm C(l) 0-glucose
ba t92 .0ppm C(l) α-glucose
c at 76.2 ppm C(5) 0-glucose
d at 76.0 ppm C(3) 0-glucose
e at 74.3 ppm C(2) -glucose
f at 73.0 ppm C(3) α-glucose
g at 71.7 ppm C(2,5) α-glucose
h at 70.0 ppm C(4) a, 0-glucose
i at 60.9 ppm C(6) a, 0-glucose
Resonance assignment in (C) according to the signals ob-
served in vivo (cf. Table 1). Each spectrum represents
5000 aquisitions with a recycle delay of 6 s and a flip
angle of 40°. An artificial line broadening of 2 Hz was
used.
Only the region between 60 and 100 ppm is
shown which is characteristic of the glucose
resonances. Fig. 4A is the spectrum of a diabetic
control rat without infusion, Fig. 4B that of a
diabetic rat after infusion of [ 1,3-13C]octanoate
while Fig. 4C is the difference spectrum B-A.
The most intense signal is that of the C(3)
resonance of 3-hydroxybutyrate at 65.4 ppm
which has been truncated in Fig. 4. The assign-
ment of the other resonances to the various
glucose carbon atoms is summarized in Table 1
and is based on a comparison with standards.
Fig. 4C then provides evidence for a distinct
flow of 13C label into carbon atoms C(3) and
C(4) of a- and j3-glucose and for a relatively high
rate of gluconeogenesis in the diabetic state.
Finally, we need to consider the question of
transitory octanoate esterification. Medium
chain fatty acids such as octanoate are generally
believed not to serve directly as substrates for
triacylglycerol formation13'10'11!. Hence, the correct
identification of the resonances at 172 ppm and
24.8 ppm observed in in vivo liver spectra after
infusion of [l,3-13C]octanoate was of major
importance. To this purpose, the 13C-NMR spec-
trum of the infusion solution containing free
[l,3-13C]octanoate was measured first. The
chemical shifts of carbon atoms C(l) and C(3)
were determined as 184.3 ppm and 25.7 ppm,
respectively, and were clearly different from
those observed under in vivo conditions (Table 2).
Thus the occurrence of free [l,3-13C]octanoate
in the liver could be excluded. Next, methanol-
chloroform extracts of the excised livers of
diabetic rats were prepared. The corresponding
13C-NMR spectra of the extracted lipids (dis-
solved in CDC13) are shown in Fig. 5 with
Fig. 5A as a control (no infusion), Fig. 5B after
infusion of [l,3-13C]octanoate, and 5C as the
difference spectrum B-Α. The difference spec-
trum contains strong resonances at 173.4 ppm
and 24.7 which are close to those observed in
vivo liver. By contrast, free [l,3-13C]octanoate
in CDC13 has resonances at 180.5 ppm and
24.7 ppm (cf. Table 2). The solubility of the
unknown metabolite in chloroform/methanol
together with the observation that the natural
abundance 13C-NMR spectra of triacylglycerols
are characterized by resonances at 171.6 ppm
(C(l)) and 24.9 ppm (C(3))il2'21) suggests an
esterification of [l,3-13C]octanoate in the dia-
betic rat liver. The formation of a thioester can
be excluded since the corresponding carbonyl
resonances occur at 195 ppm1221.
A final proof for the esterification could be
established by incubation of rat liver slices with
lipase, an enzyme which selectively cleaves the
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Table 2. Chemical shifts (in ppm) relative to IMS = 0.
Substrate
Infusate - 0.2M solution of [l,3-13CJoctanoate (pH 7.3)




Observed in vivo after infusion of [l,3-13C]octanoate
Thio-esterl221
[l,3-13CJoctanoic acid in CDC13




















carbonyl ester linkage in triacylglycerols. The
reaction could be followed in vitro with 13C-
NMR and Fig. 6 summarizes the spectra of the
carbonyl region before (6A) and after addition
of lipase (6B). The liver was excised from dia-
betic rat after infusion of [l,3-13C]octanoate.
The intense ester signal at 172 ppm in (6A) is
decreased upon lipase treatment while a new
resonance at 184.2 ppm is observed, which must
be attributed to free octanoate. Lipase treat-
ment also releases natural long-chain fatty acids.
However, the carbonyl resonances of palmitate
and oleate occur at 181-182 ppm1131 and can
thus be differentiated from octanoate.
Fig. 5. 13C-NMR spectra (at 75.5 MHz) of
extracted lipids dissolved in CDC13.
Lipids obtained from the liver of (A) a
diabetic control rat and (B) a diabetic rat
after the infusion of [l,3-13C]octanoate;
(C) difference spectrum (B) — (A) showing
only two resonances which have been
labeled during the infusion of [ 1,3-13C]-
octanoate. A chemical shift of 173.4 ppm
is typical for the carbonyl group of triacyl-
glycerol esters of fatty acids. Each spectrum
represents 3000 aquisitions with a recycle
delay of 3 s and a flip angle of 40°. An
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Fig. 6. In vitro spectra (at 75.5 MHz) of the liver
of a diabetic rat after the infusion of [ 1,3-13C]-
octanoate before (A) and after (B) incubation with
lipase.
Only the region of the carbonyl resonances is
shown. The signal at 172 ppm was assigned to the
triacylglycerol ester of octanoate, the signal at
184.2 ppm to free octanoate. The temperature was
maintained at 37 °C throughout the measurements.
Discussion
It is a widely held view that medium chain fatty
acids such as octanoic acid do not serve as sub-
strates for triacylglycerol formation13'10'111.
Surprisingly, the 13C-NMR experiments with
[ l,3-13C]octanoate provide unambiguous evi-
dence for a rather rapid esterification of part of
the infused fatty acid, this effect being observed
in the liver of fasted as well as diabetic rats. The
accumulation of the octanoate ester in the liver
is only transient. The intensity of the ester reso-
nances reaches its maximum at the end of in-
fusion and decreases to 20% of this value within
one hour. The present experiments allow no
decision if the ester bond is split in the liver or
if the ester is exported from the liver tissue.
Treatment with triacylglycerol lipase releases
free [l,3-13C]octanoate indicating that the
labeled octanoic acid was incorporated into a
triacylglycerol. The quantitative extent of
octanoate incorporation into triacylglycerol
was generally in the same order as shown in
Figs. 1 and 2, but was found drastically in-
creased in one experiment. Free octanoate
could not be detected in rat liver under in vivo
conditions.
These results differ from those obtained with
13C-labeled butyrate. Even though butyrate and
octanoate were infused at the same molar con-
centrations, the in vivo liver spectra after buty-
rate infusion always showed resonances charac-
teristic of free butyrate. On the other hand, no
butyrate ester signals were observed in the previ-
ous experiments^1>2 J .
The in vivo 13C-NMR studies with [ 1,3-13C]-
octanoate as infusate differ from in vitro studies
on perfused liver using radioactively labeled
[l-14C]octanoate[3]. The amount of labeled
ketone bodies produced from the radioactively
labeled octanoate, which was applied at high
loads, was approximately identical for both
diabetic and fasted rats. In diabetic rats only a
modest depression of the activity of the citrate
cycle was observed. However, the total ketone
body production (radioactively labeled plus
nonlabeled ketones originating from endogenous
long chain fatty acids) was twice as high in the
liver of diabetic than in that of fasted rats.
In contrast, it is evident from the present in
vivo study that the distribution of the 13C label
between the citrate cycle and the pathway of
ketogenesis is strikingly different for fasted and
diabetic rats. In the fasted state the major 13C-
labeled metabolites produced are those of the
citrate cycle, in the diabetic state mainly keto-
genic end products are observed. Hence, unlike
the in vitro studies with perfused liver131 in vivo
13C-NMR provides evidence for a control of the
ketone body production from octanoate at the
level of the disposal of acetyl-CoA between the
citrate cycle and the pathway of ketogenesis.
The enhanced rate of ketone body production
in the diabetic state is accompanied by a con-
comitant increase in the rate of gluconeogenesis
114-17] jn agreement with these earlier studies
we observed signals of 13C-lab3led glucose in
vivo in the liver of diabetic animals only. In
fasted rat the concentration of labeled glucose
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was too low (< O.SmM) to be detectable at the
present 13C-NMR sensitivity.
In mammals, fatty acids do not directly serve as
substrates for gluconeogenesis. Therefore the
pathway of 13C label from the infused fatty
acid to glucose needs to be considered in more
detail. As precursors for glucose formation
serve three-carbon substrates such as lactate,
alanine, glycerol or pyruvate. In order to be
converted to glucose, pyruvate must first enter
into the mitochondria, where it is transformed
to oxaloacetate by the action of pyruvate carb-
oxylase. The oxaloacetate formed from pyruvate
mixes with the intermediary oxaloacetate pool
of the Krebs cycle. By a variety of different
models the extent of mixing between the two
pools has been estimated to be in the range of
5 to 30%118~20J. By this exchange mechanism
[ l-13C]acetyl-CoA which has been incorporated
into four-carbon dicarboxylic acids of the
citrate cycle can also enter the pathway of
gluconeogenesis. As a second mechanism oxida-
tion of [1,3-13C]octanoate produces 13C-labeled
hydrogen carbonate which may, in part, be
added to pyruvate. The resulting oxaloacetate is
then labeled at carbon atoms C(l) as shown in
Fig. 7A. This label (noted by an asterix) is
scrambled via the fumarase exchange reaction
and appears at carbon atoms C(l) and C(4) of
malate (Fig. 7B). Malate (1) is exported into the
cytosol where it is converted via oxaloacetate
(2) into phosphoerco/pyruvate (3). Phosphoenol-
pyruvate is further converted into glycerol-
aldehyd 3-phosphate (4), which is in equilibrium
with dihydroxyacetone 1-phosphate (5). These
substrates may then be utilized for gluconeo-
genesis. A 13C label originally located in C(l) or
C(4) of malate would thus finally end up in the
C(3) and C(4) carbon atoms of glucose.
An enrichment of I3C label in glucose was ob-
served with either [ l,3-13C]octanoate (this
work) or [l,3-13C]butyratel2) as substrates, but
only in diabetic animals. At the same time only
little 13C-labeled hydrogen carbonate and
glutamate were produced in the liver of diabetic
animals and the corresponding resonances were
at the limit of detectability under in vivo condi-














pyruvate oxaloacetate malate fumarate
Fig. 7. Metabolic 13C-labeling pattern of
glucose after infusion of [ 1,3-13C]octanoate.
The position of the 13C label is indicated
by an asterix. (A) Formation of 13C-labeled
oxaloacetate via the pyruvate carboxylase
reaction and subsequent scrambling of the
label in the fumarase exchange reaction;
(B) formation of glucose starting from 13C-
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cose thus provides evidence for a concomitant
increase in the activity of the malate shuttle. Via
this mechanism NADH is exported from the
mitochondria into the cytosol where it is con-
sumed in gluconeogenesis. Due to the high rate
of j3-oxidation in the diabetic state, NADH is
produced in excess in the mitochondria creating
a reduced redox state. The oxidation capacity of
the liver would soon be limited by respiratory
control if there was not a high consumption of
NADH in gluconeogenesis and if acetyl-CoA
would not be directed into ketogenesis resulting
in the generation of less NADH than via oxida-
tion in the citrate cycle.
The high rate of j3-oxidation in the diabetic state
generates a reduced redox-state inside the mito-
chondria. Directing acetyl-CoA into ketogenesis
and not into the citrate cycle results in the
generation of less NADH and enhances the oxi-
dation capacity of the liver which might other-
wise soon be limited by respiratory control. Our
studies with octanoate and butyrate*21 provide
evidence that the redox-state in the mitochon-
dria and the concentration of free oxaloacetate is
of major importance for the regulation of keto-
genesis as has been suggested by Wieland^6'7j.
This control mechanism is probably more im-
portant than the control of the entry of fatty
acids into the mitochondria via the carnitine
acyl transferase systemi4>201.
We are indebted to P. Ganz for the competent synthesis
of 13C-labeled octanoic acid.
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